Biomarkers of HIV-1 associated dementia: proteomic investigation of sera
<p>Abstract</p> <p>Background</p> <p>New, more sensitive and specific biomarkers are needed to support other means of clinical diagnosis of neurodegenerative disorders. Proteomics technology is widely used in discovering new biomarkers. There are several difficulties wi...
Main Authors: | Duan Fenghai, Rozek Wojciech, Wiederin Jayme, Ciborowski Pawel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-03-01
|
Series: | Proteome Science |
Online Access: | http://www.proteomesci.com/content/7/1/8 |
Similar Items
-
Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation
by: Wiederin Jayme, et al.
Published: (2010-12-01) -
Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report
by: Mosley R Lee, et al.
Published: (2008-09-01) -
Investigation of some sera biomarker levels in fascioliasis patient
by: CICEK M, et al.
Published: (2012-03-01) -
Proteomic and metabolomic characterizations of moyamoya disease patient sera
by: Qingbao Guo, et al.
Published: (2023-12-01) -
Proteomics investigation of human sera for determination of postoperative indicators of pulmonary cystic echinococcosis
by: Fatemeh Sadat Sadjjadi, et al.
Published: (2023-01-01)